Hyperlipoproteinemia Type II
Showing 1 - 25 of >10,000
Familial Hyperlipidemia Trial
Not yet recruiting
- Familial Hyperlipidemia
- (no location specified)
Apr 12, 2023
Familial Hypercholesterolemia Trial
Not yet recruiting
- Familial Hypercholesterolemia
- (no location specified)
Apr 11, 2023
Homozygous Familial Hypercholesterolemia Trial (SHR-1918)
Not yet recruiting
- Homozygous Familial Hypercholesterolemia
- (no location specified)
Aug 22, 2023
Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)
Not yet recruiting
- Hypercholesterolemia
- Familial Hypercholesterolemia
- MK-0616
- Placebo
- (no location specified)
Jul 10, 2023
Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)
Not yet recruiting
- Homozygous Familial Hypercholesterolemia
- NGGT006
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023
Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)
Not yet recruiting
- Hypercholesterolemia
- Familial Hypercholesterolemia
- MK-0616
- Placebo
- (no location specified)
Jul 10, 2023
Program With Lipid Screening asMeans to Identify Familial
Enrolling by invitation
- Familial Hyperlipidemia
-
Loveland, ColoradoMedical Center of the Rockies
Mar 2, 2023
Homozygous Familial Hypercholesterolemia Trial (Evinacumab)
Not yet recruiting
- Homozygous Familial Hypercholesterolemia
- (no location specified)
Nov 3, 2022
Familial Hypercholesterolemia Trial in Philadelphia (Cascade screening)
Enrolling by invitation
- Familial Hypercholesterolemia
- Cascade screening
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, Perelman School of Medicine
Feb 27, 2023
Return of Actionable Variants Empirical Study
Completed
- Familial Hypercholesterolemia
- (no location specified)
Sep 26, 2022
l Gene Editing Therapy for Cardiovascular Disease
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
-
Auckland, New Zealand
- +2 more
Oct 31, 2023
Advanced Lipoproptein Profiling and Cardiovascular Risk
Recruiting
- Familial Hypercholesterolemia
- Atherosclerosis
- Additionnal blood samples
-
Paris, FranceHôpital de la Pitié Salpêtrière
Aug 2, 2022
Familial Hypercholesterolemia Trial (phytosterol, krill oil, Placebo phytosterol)
Not yet recruiting
- Familial Hypercholesterolemia
- phytosterol
- +3 more
- (no location specified)
Jan 13, 2023
Familial Hypercholesterolemia, Atherosclerosis Trial (Visualization of coronary Imaging and oral description)
Not yet recruiting
- Familial Hypercholesterolemia
- Atherosclerosis
- Visualization of coronary Imaging and oral description
- (no location specified)
Mar 6, 2023
Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)
Not yet recruiting
- Hypercholesterolemia
- +3 more
- Inclisiran
- +2 more
-
Cambridge, United KingdomUniversity of Cambridge
Jan 13, 2023
Cardiovascular Risk Markers in Familial Hypercholesterolemia
Recruiting
- Familial Hypercholesterolemia
-
Oslo, NorwayOslo University Hospital
Oct 12, 2022
Familial Hypercholesterolemia, Cholesterol, Elevated, Genetic Disease Trial in Duluth (Motivational interview (MI))
Recruiting
- Familial Hypercholesterolemia
- +2 more
- Motivational interview (MI)
-
Duluth, Minnesota
- +1 more
Feb 1, 2023
Familial Hypercholesterolemia Trial in Madrid (Alirocumab)
Completed
- Familial Hypercholesterolemia
-
Madrid, SpainFundacion Hipercolesterolemia Familiar
Jul 15, 2022
Familial Hypercholesterolemia Trial in Philadelphia (Testing centralized referral mechanisms for PCPs, Testing out patient
Active, not recruiting
- Familial Hypercholesterolemia
- Testing centralized referral mechanisms for PCPs
- Testing out patient outreach methods
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Health System
Feb 17, 2023
Individuals With Familial Hypercholesterolemia
Not yet recruiting
- Familial Hypercholesterolemia
- Cascade Screening
- (no location specified)
Jun 17, 2022
Familial Hypercholesterolemia Trial in Nashville (2-Hydroxybenzylamine, Placebo)
Not yet recruiting
- Familial Hypercholesterolemia
- 2-Hydroxybenzylamine
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Nov 4, 2022
Long QT Syndrome, Familial Hypercholesterolemia, Ethics Trial (Direct contact of family members for cascade screening of
Not yet recruiting
- Long QT Syndrome
- +3 more
- Direct contact of family members for cascade screening of relevant variants
- (no location specified)
Aug 15, 2022
Familial Hypercholesterolemia Trial in Odense C (Biochemistry interpretive comment on elevated LDL-C levels)
Not yet recruiting
- Familial Hypercholesterolemia
- Biochemistry interpretive comment on elevated LDL-C levels
-
Odense C, DenmarkDepartement of Cardiology, Odense University Hospital
Nov 10, 2022
Heterozygous or Homozygous Familial Hypercholesterolemia Trial (Inclisiran)
Not yet recruiting
- Heterozygous or Homozygous Familial Hypercholesterolemia
- (no location specified)
Dec 27, 2022